Orchestra BioMed says investigational AVIM hypertension therapy features in HRX Live sessions
OBIO•AVIM Therapy to be featured at HRX Live 2026
Orchestra BioMed says it will present AVIM Therapy in two sessions at HRX Live 2026 in Atlanta on Sept. 18-20, 2026.
- A Medtronic collaboration roundtable is scheduled for Sept. 19, 2026, 9:40-10:25 a.m. ET, highlighting AVIM for uncontrolled hypertension.
- A second panel on pacing beyond bradycardia is set for Sept. 18, 2026, 4:45-5:30 p.m. ET, featuring AVIM.
Related News
Capstone reaffirms 2026 outlook for $72.1 million revenue, $18.7 million gross profit, $3.8 million adjusted EBITDA
CAPS•
eHealth survey: 54% of small, mid-sized employers face 10%+ health plan premium increases for 2027
EHTH•
